Literature DB >> 18852564

Neuroethics and psychiatry.

Neil Levy1, Steve Clarke.   

Abstract

PURPOSE OF REVIEW: The field of neuroethics is experiencing a great deal of activity at present, as researchers come to realize the potentially dramatic implications of new work in neuroscience and its applications. This review aims to describe some of the work of direct relevance to psychiatric ethics. RECENT
FINDINGS: The review focuses on ethical issues surrounding the use of propranolol to treat or prevent posttraumatic stress disorder, issues concerning the capacity of the mentally ill to give informed consent to medical treatment and the potential social implications of cognitive enhancers and other interventions into the mind.
SUMMARY: It is argued that psychiatric ethics would benefit from a consideration of cognate questions arising in neuroethics; in particular, neuroethics has the potential to remind psychiatrists that individual treatment decisions can have broad social implications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852564     DOI: 10.1097/YCO.0b013e3283126769

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  3 in total

1.  Response of the German Society of Neuroradiology to the guideline : "Ethically Appropriate Reaction to Incidental Imaging Findings in Brain Research", suggested by Thomas Heinemann, Institut für Wissenschaft und Ethik, and Christian Hoppe, Klinik für Epileptologie, Universität Bonn, Germany, on January 9, 2009.

Authors:  Frank Hentschel; Rüdiger von Kummer
Journal:  Klin Neuroradiol       Date:  2009-06

2.  The neuroethics of non-invasive brain stimulation.

Authors:  Roi Cohen Kadosh; Neil Levy; Jacinta O'Shea; Nicholas Shea; Julian Savulescu
Journal:  Curr Biol       Date:  2012-02-21       Impact factor: 10.834

3.  "This is Why you've Been Suffering": Reflections of Providers on Neuroimaging in Mental Health Care.

Authors:  Emily Borgelt; Daniel Z Buchman; Judy Illes
Journal:  J Bioeth Inq       Date:  2011-03-01       Impact factor: 1.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.